These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 8722520)
21. Congress punts on SBIR reauthorization. Thiel K Nat Biotechnol; 2009 Dec; 27(12):1065-6. PubMed ID: 20010562 [No Abstract] [Full Text] [Related]
22. Human tissue research: who owns the results? Wagner AB J Pat Trademark Off Soc; 1987 Jun; 69(6):329-52. PubMed ID: 11649984 [No Abstract] [Full Text] [Related]
23. Medical innovation at the crossroads. Laubach GD; Gelijns AC Issues Sci Technol; 1995; 11(3):33-40. PubMed ID: 10141894 [No Abstract] [Full Text] [Related]
24. Should the patent system for new medicines be abolished? DiMasi JA; Grabowski HG Clin Pharmacol Ther; 2007 Nov; 82(5):488-90. PubMed ID: 17952100 [No Abstract] [Full Text] [Related]
25. Responding to stimuli. Mahapatra A ACS Chem Biol; 2009 Apr; 4(4):233. PubMed ID: 19371128 [No Abstract] [Full Text] [Related]
27. Proprietary rights and the norms of science in biotechnology research. Eisenberg RS Yale Law J; 1987 Dec; 97(2):177-231. PubMed ID: 11660398 [No Abstract] [Full Text] [Related]
29. The costs of medical technology. Chernew M Mich Health Hosp; 1997; 33(2):40-2. PubMed ID: 10165611 [No Abstract] [Full Text] [Related]
30. Federal actions against plagiarism in research. Price AR J Infor Ethics; 1996; 5(1):34-51. PubMed ID: 11653389 [No Abstract] [Full Text] [Related]
31. Managing innovation: university-industry partnerships and the licensing of the Harvard mouse. Blaug S; Chien C; Shuster MJ Nat Biotechnol; 2004 Jun; 22(6):761-4. PubMed ID: 15175696 [No Abstract] [Full Text] [Related]
32. Research on embryonic tissue, ethics, and congressional inquiry. Maloney DM Hum Res Rep; 1999 Jan; 14(1):6. PubMed ID: 11657559 [No Abstract] [Full Text] [Related]
33. The economics of abortion access in the US: restrictions on government funding for abortion is the post-Roe battleground. Fried MG Conscience; 2005-2006; 26(4):11-5. PubMed ID: 16619422 [No Abstract] [Full Text] [Related]
34. The market and medical innovation: human passions and medical advancement. Cherry MJ J Med Philos; 2005 Dec; 30(6):555-69. PubMed ID: 16396784 [No Abstract] [Full Text] [Related]
35. Addressing ethical issues in biomedicine: national policy perspectives. Hatfield MO Acad Med; 1994 Jul; 69(7):558-9. PubMed ID: 11644542 [No Abstract] [Full Text] [Related]
36. Two ideas to increase innovation and reduce pharmaceutical costs and prices. Jayadev A; Stiglitz J Health Aff (Millwood); 2009; 28(1):w165-8. PubMed ID: 19088104 [TBL] [Abstract][Full Text] [Related]
37. Equitable access to biomedical advances: getting beyond the rights impasse. Mariner WK Conn Law Rev; 1989; 21(3):571-603. PubMed ID: 11650430 [No Abstract] [Full Text] [Related]
38. Medical innovations and ethics: a state government perspective. Swidler RN Albany Law Rev; 1994; 57(3):655-77. PubMed ID: 11652859 [No Abstract] [Full Text] [Related]
39. Bioinformatics. Petition seeks public sharing of code. Malakoff D Science; 2001 Oct; 294(5540):27. PubMed ID: 11588225 [No Abstract] [Full Text] [Related]
40. Federally funded stem cell research: a good deal for the taxpayer and consumer. Resnikoff DA Loyola Consum Law Rev; 2001; 14(1):36-56. PubMed ID: 15977330 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]